Biopharma Co. Blasts 'Excessive' Fee Bid In Board Pay Case
After striking a tentative deal to settle a Delaware Chancery suit he filed over alleged "grossly excessive" director pay, an investor plaintiff is now seeking an "excessive" payday for his attorneys,...To view the full article, register now.
Already a subscriber? Click here to view full article